关键词：动脉斑块；旋切术装置；消除；粥样硬化斑块；疏通堵塞；血管内手术；PAD；CAD
摘 要：Atherectomy devices are used to remove atherosclerotic plaque to clear blocked blood vessels. Atherosclerotic plaques are deposits of fats, calcium, or other substances inside the blood vessels. Removal of these is an endovascular procedure for the treatment of PAD and CAD. PVD refers to damaged or blocked peripheral blood vessels that supply blood to the arms, legs, and organs other than brain and heart. PAD, which is PVD of the arteries, is known to increase the risk of stroke and heart attack by up to six fold. CAD is a condition in which there is narrowing of the arteries that supply blood to heart muscles. Stents, balloon catheters, and atherectomy devices are used in endovascular procedures to treat PVD. Thrombectomy devices are used to surgically remove thrombi (clots) from blood vessels during the treatment of DVT. A DVT is a blood clot formed in deep veins in the body, mainly in the leg. The risk of developing these vascular diseases increases with age. Diabetes, high blood pressure, obesity, and smoking are other risk factors of these diseases.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

03.2.1 Atherectomy Products

03.2.2 Thrombectomy Products

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Global Atherectomy and Thrombectomy

Devices Market

06.1 Market Overview

06.1.1 Market Size and Forecast

07. Global Atherectomy and Thrombectomy

Market Segmentation by Product Type

07.1 Atherectomy Devices

07.2 Thrombectomy Devices

07.3 Five Forces Analysis

08. Global Atherectomy Devices Market

08.1 Market Overview

08.1.1 Market Size and Forecast

08.2 Market Segmentation by Procedure Type

09. Global Thrombectomy Devices Market

09.1 Market Overview

09.1.1 Market Size and Forecast

09.2 Market Segmentation by Product Type

09.3 Market Segmentation by Procedure Type

10. Reimbursement Scenario of Atherectomy

and Thrombectomy Devices

10.1 Reimbursement Scenario in Americas

10.2 Reimbursement Scenario in EMEA

10.3 Reimbursement Scenario in APAC

11. Geographical Segmentation

11.1 Atherectomy and Thrombectomy Devices

Market in Americas

11.1.1 Market Size and Forecast

11.2 Atherectomy and Thrombectomy Devices

Market in EMEA

11.2.1 Market Size and Forecast

11.3 Atherectomy and Thrombectomy Devices

Market in APAC

11.3.1 Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Vendor Analysis 2015

19.2.1 Boston Scientific Group

19.2.2 Cardiovascular Systems

19.2.3 Medtronic

19.2.4 Spectranetics

19.2.5 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Boston Scientific Group

20.1.1 Key Facts

20.1.2 Business Overview

20.1.3 Business Segmentation

20.1.4 Business Strategy

20.1.5 Business Segmentation by Revenue

20.1.6 Business Segmentation by Revenue 2012 and 2013

20.1.7 Geographical Segmentation by Revenue

20.1.8 Key Developments

20.1.9 SWOT Analysis

20.2 Cardiovascular Systems

20.2.1 Key Facts

20.2.2 Business Overview5

20.2.3 Product Segmentation Based on Therapy Areas

20.2.4 Business Strategy

20.2.5 Recent Developments

20.2.6 SWOT Analysis

20.3 Medtronic

20.3.1 Key Facts

20.3.2 Business Overview

20.3.3 Business Segmentation by Revenue 2013

20.3.4 Business Segmentation by Revenue 2012 and 2013

20.3.5 Geographical Segmentation by Revenue 2013

20.3.6 Business Strategy

20.3.7 Recent Developments

20.3.8 SWOT Analysis

20.4 Spectranetics

20.4.1 Key Facts

20.4.2 Business Overview

20.4.3 Business Segmentation 2014

20.4.4 Business Segmentation by Revenue 2013 and 2014

20.4.5 Geographical Segmentation by Revenue 2014

20.4.6 Business Strategy

20.4.7 Recent Developments

20.4.8 SWOT Analysis

21. Other Reports in this Series